Tracking tumor resistance using 'liquid biopsies'. (Q48721300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Tracking tumor resistance using 'liquid biopsies' (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Klaus Pantel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

676-677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

2 March 2020

cites work

1 reference

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing

21 January 2018

1 reference

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

Development of personalized tumor biomarkers using massively parallel sequencing

21 January 2018

1 reference

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

21 January 2018

1 reference

Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing

21 January 2018

1 reference

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/23744147

21 January 2018

1 reference

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23744147

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23744147

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.3233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744147%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference